Cysteine for Hair and Nails

Hair and nails are made of keratin, and keratin is held together by disulfide bonds — covalent cross-links between the sulfur atoms of cysteine residues in adjacent keratin protein chains. By weight, hair is approximately 14-18% cysteine, the highest cysteine content of any tissue in the human body. Nail plate is similar. The disulfide bond is the single structural feature that gives hair and nails their characteristic strength, elasticity, and resistance to deformation — and it is the bond that hair perming and straightening chemistry deliberately reduces and re-forms to remodel hair shape. Clinical supplementation trials of L-cystine (the oxidized cysteine dimer) at doses of 70-200 mg/day, typically in the European Pantogar / Pantovigar formulation that combines cystine with B vitamins, keratin, and medicinal yeast, show modest but measurable benefit for diffuse hair shedding (telogen effluvium) and brittle-nail syndrome — effects that biotin monotherapy at standard supplement doses cannot reproduce, because the limiting nutrient in keratin protein synthesis is cysteine, not biotin.

Table of Contents

  1. Keratin Structure and the Disulfide Bond
  2. Cysteine Content in Hair Shaft
  3. The Nail Plate and Onychorrhexis
  4. Perming and Straightening Chemistry (Real-World Disulfide Manipulation)
  5. Telogen Effluvium and Cysteine
  6. The Pantogar / Pantovigar Formulation
  7. L-Cystine vs L-Cysteine vs NAC for Hair
  8. Why Biotin Alone Is Not Enough
  9. The Full Nutritional Stack (Iron, Zinc, Vitamin D, Protein)
  10. Brittle Nail Syndrome (Onychoschizia)
  11. Practical Dosing
  12. Key Research Papers
  13. Connections

Keratin Structure and the Disulfide Bond

Keratin is the structural protein that builds hair, nails, skin stratum corneum, claws, hooves, feathers, and the horny outer layer of essentially all vertebrate body coverings. The human genome encodes more than 50 distinct keratin genes, divided into two families: type I (acidic) keratins and type II (basic) keratins. A functional keratin filament is assembled from heterodimers of one type I + one type II keratin chain, which then form parallel coiled-coil dimers, then antiparallel tetramers, then progressively larger filament structures up to the visible hair shaft.

The keratin types found in hair and nails are the so-called "hard" keratins (K31-K40 and K81-K86), which differ from the "soft" keratins of epidermis primarily in their dramatically higher cysteine content. Hard keratins contain 10-17% cysteine residues by mole, compared to 2-3% in epidermal soft keratins. This high cysteine density is what enables the dense disulfide cross-linking that gives hard keratin its mechanical strength.

The cysteine cross-link is formed when two cysteine residues, one on each of two adjacent keratin chains, oxidize their thiol groups to form a covalent S–S disulfide bond. This bond is roughly 200 times stronger than the typical hydrogen bond and 5-10 times stronger than the typical ionic bond that holds protein structures together. A single hair shaft contains millions of these disulfide cross-links, and their density is what determines whether a particular hair is fine and floppy or coarse and rigid. African-type hair has the highest disulfide cross-link density and is therefore the strongest per unit cross-section, although the high cross-link density also makes it more susceptible to mechanical breakage at the surface during styling. Asian-type hair has intermediate density and produces the round, straight, thick hair fibers characteristic of East Asian populations. European-type hair has the lowest density and produces the variable wave and lighter cross-section seen in Northern European populations.

Beyond intermolecular disulfide bonds within keratin filaments, additional disulfide cross-linking occurs between keratin and the keratin-associated proteins (KAPs), a separate gene family of cysteine-ultra-rich proteins (some KAPs are 30% cysteine by mole) that fill the spaces between keratin filaments in the hair-shaft matrix. The combined system is sometimes called the cysteine-rich intermediate filament + KAP network, and it is the single most cysteine-intensive structural assembly in human anatomy.

Back to Table of Contents

Cysteine Content in Hair Shaft

Quantitatively, the amino acid composition of a human hair shaft is approximately 14-18% cysteine, 12% glutamic acid, 11% arginine, 10% serine, 9% threonine, with smaller proportions of the other amino acids. Cysteine is the single most abundant residue. For comparison, the average amino acid composition of total body protein is about 2% cysteine — meaning hair concentrates cysteine roughly 7-fold above the body-wide average.

This high cysteine density has metabolic consequences. Growing a head of hair (roughly 100,000 hair follicles producing approximately 1 cm of new hair per month) requires the body to direct a measurable fraction of its total cysteine supply into the hair shafts. In conditions of total dietary protein restriction or sulfur amino acid deficiency, hair growth slows visibly within weeks and hair shafts become finer, weaker, and lighter in color (because the cysteine in melanin-stabilizing proteins is also reduced). Severe protein malnutrition produces the depigmented, sparse, fragile hair of kwashiorkor.

The reverse is also true: cysteine demand for hair growth is a meaningful contributor to total sulfur amino acid requirement, and elderly adults who reduce protein intake will frequently notice hair thinning months before any other clinical sign of inadequate protein nutrition. The strands themselves do not "remember" later improvements in nutrition — each hair shaft records the cysteine status of the body at the moment its follicle synthesized it, and only new growth reflects subsequent improvements.

Back to Table of Contents

The Nail Plate and Onychorrhexis

The nail plate is also composed of hard keratin (specifically K6a, K16, K17 for the dorsal nail; K31, K85, K86 for the deeper bulk of the plate), with comparable cysteine density to hair. The nail matrix at the base of each nail (under the cuticle) is the site of keratin synthesis; cells generated in the matrix flatten, fill with keratin, lose their nuclei, and become the translucent nail plate that grows outward at about 3 mm per month for fingernails and 1 mm per month for toenails.

Brittle nail syndrome (onychoschizia — horizontal splitting of the nail tip; or onychorrhexis — longitudinal ridging and brittleness) affects approximately 20% of adults and is more common in women, in people over 50, and in people with frequent water and detergent exposure. Cysteine deficiency or marginal status is one of several contributing causes, alongside iron deficiency, hypothyroidism, biotin marginal status, dehydration, and frequent solvent exposure (e.g., acetone-based nail polish removers).

Clinically, the nail-strengthening evidence for sulfur amino acid supplementation is best characterized in the European clinical literature using the Pantogar / Pantovigar formulation (discussed below). Several open-label and a few small randomized trials have shown nail-thickness, nail-hardness, and patient-perceived-quality improvements over 3-6 months of supplementation. The effect size is modest but consistent, and the safety profile is excellent.

Back to Table of Contents

Perming and Straightening Chemistry (Real-World Disulfide Manipulation)

The clearest practical demonstration of cysteine's structural role in hair is the chemistry of permanent waving and chemical straightening. A "perm" works in three steps. First, a thiol reducing agent (traditionally ammonium thioglycolate, more recently cysteamine or pure cysteine itself in gentler formulations) is applied to the hair and breaks the disulfide bonds between keratin chains. With the cross-links broken, the keratin filaments can slide relative to each other and the hair becomes pliable, taking the shape of whatever curlers or rollers are applied. Second, the hair is mechanically held in the desired shape. Third, a neutralizer (usually hydrogen peroxide or sodium bromate) re-oxidizes the now-mobile cysteine thiols back into disulfide bonds, but in their new geometry — locking the hair into the new curl pattern.

Chemical straightening (Brazilian blowouts, Japanese thermal reconditioning, traditional alkaline relaxers) uses similar but stronger chemistry: more aggressive reducing or denaturing agents (sodium hydroxide, ammonium thioglycolate at higher concentrations, or formaldehyde-releasing systems) break more cross-links to allow the hair to be heat-pressed straight, then the cross-links re-form in the straightened conformation.

The damaging effect of repeated perming and chemical straightening is partly mechanical, but it is primarily chemical — each cycle of disulfide reduction and re-oxidation does not perfectly restore the original cross-link pattern. Some cysteines are oxidized to cysteic acid (the fully oxidized SO3H sulfonic acid form) rather than re-forming disulfide bonds, and those sulfonic acid groups cannot re-cross-link. Over time, the hair shaft accumulates cysteic acid in place of cysteine cross-links, weakening progressively.

The point of mentioning all this in a clinical context: the structural integrity of hair is literally a function of intact cysteine residues. Anything that disrupts cysteine availability for keratin synthesis (poor nutrition, malabsorption, chronic illness) or anything that damages cysteine in existing hair (chemical processing, UV exposure, chlorinated pool water) will produce visible hair degradation. Repleting cysteine through diet and supplementation supports the manufacture of new, structurally-normal hair shafts; it cannot repair the cysteine damage in existing shafts — only new growth reflects the intervention.

Back to Table of Contents

Telogen Effluvium and Cysteine

Telogen effluvium is the most common form of diffuse hair shedding seen in adults. The mechanism is a synchronized premature transition of hair follicles from the active growth (anagen) phase into the resting (telogen) phase, followed by shedding of the telogen hairs 2-4 months later. Common triggers include severe illness, fever, surgery, childbirth, rapid weight loss, severe psychological stress, iron deficiency, and starting or stopping certain medications (especially hormonal contraceptives, antidepressants, anticoagulants, and beta-blockers).

Chronic telogen effluvium — diffuse shedding lasting longer than 6 months — often has multiple contributing causes including marginal sulfur amino acid status. Several trials have evaluated cystine-containing supplementation protocols in this condition. The Lengg-Trueb 2007 trial randomized 30 women with diffuse alopecia to receive Pantogar (cystine + thiamine + keratin + medicinal yeast + p-aminobenzoic acid) or placebo for 6 months. The treatment group showed significantly higher anagen-to-telogen ratios (i.e., more growing hair, fewer resting hair) at 6 months, with the effect appearing around month 3 and increasing through the end of the trial.

Other small trials have shown similar benefit for combination cystine-containing products. Cystine monotherapy at 70-200 mg/day has not been as rigorously studied as the combination products, but several open-label observations suggest meaningful effect on hair density measures.

The clinical pattern for cystine-responsive hair loss is the diffuse, non-scarring, post-stressor pattern of telogen effluvium — not the patterned androgenetic alopecia of male-pattern or female-pattern baldness (which responds to minoxidil, finasteride, or spironolactone), and not the patchy alopecia areata (autoimmune, responds to steroids or immunomodulators). Cystine is structural-substrate therapy, not hormonal or immunologic therapy.

Back to Table of Contents

The Pantogar / Pantovigar Formulation

Pantogar (brand name in Germany, Austria, Switzerland; sold as Pantovigar in some markets, also marketed under the original brand as Priorin in some countries; Pantovigar is the registered Schwarzhaupt / Merz formulation) is the most clinically-studied hair-supplementation product on the European market. The capsule contains:

The standard regimen is 1 capsule three times daily with meals (3 capsules/day total, providing 60 mg cystine + 60 mg keratin-derived cysteine) for a minimum of 3-6 months. Continuous use for 12+ months is common in clinical practice when responding.

The Pantogar formulation is intentionally a multi-nutrient stack rather than isolated cystine, on the theory that hair growth requires cysteine plus its B-vitamin cofactors (B1 and B5 for energy metabolism in the high-turnover hair matrix; PABA and yeast B-vitamins for broader cellular function). Most controlled trials have used the combination product, so the specific contribution of cystine alone is difficult to isolate, but the cystine + keratin sulfur amino acid content is the formulation's distinguishing feature compared to ordinary multivitamins.

The product is not currently FDA-registered in the US, but is available through import. Several US-marketed "hair, skin and nail" multivitamins now include cystine in similar dose ranges, often combined with biotin, zinc, and vitamin D — functionally similar to Pantogar but with somewhat different vitamin proportions.

Back to Table of Contents

L-Cystine vs L-Cysteine vs NAC for Hair

L-cystine is the oxidized dimer formed when two L-cysteine molecules link via a disulfide bond. Inside cells, cystine is rapidly reduced back to two cysteines by the cystine reductase system (powered by NADPH), making cystine and cysteine functionally interconvertible from a supplement perspective. The Pantogar formulation uses cystine specifically because the disulfide form is more shelf-stable than free cysteine and less prone to oxidation in solid dosage form.

From a hair-growth standpoint, the three available forms — L-cystine, L-cysteine, and NAC — should all deliver cysteine equivalents to the hair follicle. NAC is the most bioavailable from a glutathione-synthesis standpoint, but the kinetics of cysteine delivery to the cortical-cell keratin synthesis machinery are less well-characterized than the cytosolic GSH synthesis pathway. Most of the hair-supplementation clinical literature uses L-cystine, and that is therefore the form with the strongest direct evidence for hair endpoints.

NAC at the standard 600-1800 mg/day dosing range certainly provides ample cysteine substrate for hair growth, and patients taking NAC for other indications (COPD, NAFLD, PCOS) commonly report incidental hair-quality improvements. There is no harm in using NAC as a cysteine source for hair-growth purposes, though if the only goal is hair growth, the Pantogar-type combination products have more direct evidence than NAC monotherapy.

Back to Table of Contents

Why Biotin Alone Is Not Enough

Biotin (vitamin B7) is the most-marketed nutrient for hair growth in the US supplement market, typically sold at doses of 5,000-10,000 mcg per capsule (5-10 mg). This is roughly 200x the daily requirement of 30 mcg. Despite the marketing prominence, the actual clinical evidence for high-dose biotin in hair growth is remarkably thin.

True biotin deficiency does cause hair loss — it is one of the clinical signs of biotinidase deficiency, of the rare congenital biotin transporter mutations, and of chronic raw-egg-white consumption (which contains avidin, a biotin-sequestering protein). Biotin deficiency also produces hair loss in patients on long-term anticonvulsants (especially carbamazepine and phenobarbital) that interfere with biotin metabolism, and in patients on long-term broad-spectrum antibiotics that disturb the gut microbial biotin synthesis. For these specific deficiency states, biotin repletion clearly restores hair growth.

For the much more common situation of diffuse hair shedding in an adult without an underlying biotin deficiency, supplemental biotin at standard megadoses has not shown convincing benefit in controlled trials. A 2017 systematic review (Patel et al, Skin Appendage Disorders) found insufficient evidence to support biotin monotherapy for hair growth in patients with adequate baseline biotin status.

The mechanistic reason: biotin is a cofactor for carboxylase enzymes that operate in fatty acid and carbohydrate metabolism. It is not a structural component of keratin, and supplementing biotin above the level needed for full carboxylase saturation cannot increase keratin synthesis. By contrast, cysteine is the structural amino acid limiting keratin synthesis — raising its availability directly raises the supply of the rate-limiting substrate.

The practical implication: combination products containing both biotin (to ensure adequacy of the carboxylase pathway) and cystine (to provide the structural substrate) make more biochemical sense than biotin alone. Most modern "hair, skin, and nail" multivitamins now include both.

Two cautions about high-dose biotin worth mentioning. First, biotin doses above 5 mg/day interfere with several common immunoassay laboratory tests — including the troponin assay used to diagnose acute MI, the TSH and free T4 assays used to assess thyroid function, and several others. The FDA has issued specific warnings about this interference, which can produce false-negative troponin in patients having a heart attack. Anyone on high-dose biotin should stop the supplement at least 48-72 hours before lab work and disclose it to their physician. Second, high-dose biotin can occasionally trigger or worsen cystic acne, particularly in young women.

Back to Table of Contents

The Full Nutritional Stack (Iron, Zinc, Vitamin D, Protein)

Hair shedding is rarely caused by single-nutrient deficiency in adults eating an ordinary mixed diet. The common contributors that should be evaluated when investigating diffuse hair loss include:

The clinical takeaway is that hair-loss workup should be holistic, and cystine supplementation is most effective when stacked on a foundation of adequate protein, iron repletion, vitamin D adequacy, and resolution of any contributing thyroid or hormonal issue.

Back to Table of Contents

Brittle Nail Syndrome (Onychoschizia)

Brittle nails are an under-discussed problem with substantial impact on quality of life. The clinical pattern includes longitudinal ridging, horizontal splitting at the nail tip, peeling of the surface layers, and increased fragility producing painful catches and tears.

The nutritional approach to brittle nails parallels the hair approach: address iron deficiency, ensure adequate protein and sulfur amino acid intake, supplement biotin if there is reason to suspect inadequacy or marginal status, and provide cystine as direct keratin substrate. The single best-studied biotin trial in brittle nails (Hochman 1993) used 2.5 mg biotin daily for 6 months and showed 25% thickening of the nail plate at the end of treatment. Biotin appears to work in brittle nails in a way that it does not for hair growth in the absence of deficiency, perhaps because nail-plate cells have particularly high biotin-dependent enzyme activity.

Combined formulations of biotin + cystine + other nutrients (similar to the Pantogar approach) have not been compared head-to-head with biotin monotherapy for nail outcomes in well-powered trials. The biochemical logic favors combination, and combination products are widely sold for this indication.

Mechanical and chemical factors are also important in brittle nails — frequent hand-washing without immediate moisturization, alcohol-based hand sanitizers, frequent water immersion, acetone nail-polish removers, and gel-polish UV-cure systems all damage the nail plate independently of nutritional status. Patients with onychoschizia benefit from cotton-lined rubber gloves for wet work, replacing acetone-based removers with non-acetone (ethyl acetate or methyl ethyl ketone) products, and using a cuticle oil with phospholipids and ceramides nightly.

Back to Table of Contents

Practical Dosing

Realistic timelines: hair-shaft endpoints (visible improvement in shedding, density, thickness) take 3-6 months minimum to manifest, because each individual hair follicle moves through anagen, catagen, and telogen on a 2-7 year cycle and the synchronization of improvement takes time. Nail endpoints similarly take 6-12 months for full fingernail and 18+ months for full toenail growth-out at the natural growth rate. Patients should be counseled to commit to a minimum 6-month trial of any hair or nail supplementation protocol before judging effect.

Back to Table of Contents

Key Research Papers

  1. Lengg N, Heidecker B, Seifert B, Trueb RM (2007). Dietary supplement increases anagen hair rate in women with telogen effluvium: results of a double-blind, placebo-controlled trial. Therapy. — PubMed
  2. Trueb RM (2009). Oxidative stress in ageing of hair. International Journal of Trichology. — PubMed
  3. Petri H, Pierchalla P, Tronnier H (1990). The efficacy of drug therapy in structural lesions of the hair and in diffuse effluvium — comparative double-blind study. Schweiz Rundsch Med Prax. — PubMed
  4. Floersheim GL (1992). Behandlung bruchiger Fingernagel mit Biotin (Treatment of brittle fingernails with biotin). Z Hautkr. — PubMed
  5. Hochman LG, Scher RK, Meyerson MS (1993). Brittle nails: response to daily biotin supplementation. Cutis. — PubMed
  6. Patel DP, Swink SM, Castelo-Soccio L (2017). A review of the use of biotin for hair loss. Skin Appendage Disorders. — PubMed
  7. Rushton DH (2002). Nutritional factors and hair loss. Clinical and Experimental Dermatology. — PubMed
  8. Almohanna HM, Ahmed AA, Tsatalis JP, Tosti A (2019). The role of vitamins and minerals in hair loss: a review. Dermatology and Therapy. — PubMed
  9. Trueb RM (2016). Serum biotin levels in women complaining of hair loss. International Journal of Trichology. — PubMed
  10. Plonka PM, Handjiski B, Popik M, Michalczyk D, Paus R (2005). Zinc as an ambivalent but potent modulator of murine hair growth in vivo. Experimental Dermatology. — PubMed
  11. Park SY, Na SY, Kim JH, Cho S, Lee JH (2013). Iron plays a certain role in patterned hair loss. Journal of Korean Medical Science. — PubMed
  12. Olsen EA, Reed KB, Cacchio PB, Caudill L (2010). Iron deficiency in female pattern hair loss, chronic telogen effluvium, and control groups. JAAD. — PubMed
  13. Wickett RR, Kossmann E, Barel A et al. (2007). Effect of oral intake of choline-stabilized orthosilicic acid on hair tensile strength and morphology in women with fine hair. Archives of Dermatological Research. — PubMed
  14. Trueb RM (2016). The impact of oxidative stress on hair. International Journal of Cosmetic Science. — PubMed

PubMed Topic Searches

Back to Table of Contents

Connections

Back to Table of Contents